BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 10475388)

  • 1. Safe pulmonary resection after chemotherapy and high-dose thoracic radiation.
    Sonett JR; Krasna MJ; Suntharalingam M; Schuetz J; Doyle LA; Lilenbaum R; Gamliel Z
    Ann Thorac Surg; 1999 Aug; 68(2):316-20. PubMed ID: 10475388
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pulmonary resection after curative intent radiotherapy (>59 Gy) and concurrent chemotherapy in non-small-cell lung cancer.
    Sonett JR; Suntharalingam M; Edelman MJ; Patel AB; Gamliel Z; Doyle A; Hausner P; Krasna M
    Ann Thorac Surg; 2004 Oct; 78(4):1200-5; discussion 1206. PubMed ID: 15464470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term outcome after en bloc resection of non-small-cell lung cancer invading the pulmonary sulcus and spine.
    Collaud S; Waddell TK; Yasufuku K; Pierre AF; Darling GE; Cypel M; Rampersaud YR; Lewis SJ; Shepherd FA; Leighl NB; Cho J; Bezjak A; Tsao MS; Keshavjee S; de Perrot M
    J Thorac Oncol; 2013 Dec; 8(12):1538-44. PubMed ID: 24389435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Standard-dose versus high-dose conformal radiotherapy with concurrent and consolidation carboplatin plus paclitaxel with or without cetuximab for patients with stage IIIA or IIIB non-small-cell lung cancer (RTOG 0617): a randomised, two-by-two factorial phase 3 study.
    Bradley JD; Paulus R; Komaki R; Masters G; Blumenschein G; Schild S; Bogart J; Hu C; Forster K; Magliocco A; Kavadi V; Garces YI; Narayan S; Iyengar P; Robinson C; Wynn RB; Koprowski C; Meng J; Beitler J; Gaur R; Curran W; Choy H
    Lancet Oncol; 2015 Feb; 16(2):187-99. PubMed ID: 25601342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resection of lung cancer is justified in high-risk patients selected by exercise oxygen consumption.
    Walsh GL; Morice RC; Putnam JB; Nesbitt JC; McMurtrey MJ; Ryan MB; Reising JM; Willis KM; Morton JD; Roth JA
    Ann Thorac Surg; 1994 Sep; 58(3):704-10; discussion 711. PubMed ID: 7944692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Postoperative adjuvant therapy in combined lung cancer treatment].
    Cicenas S; Piscikas DA; Jakubauskiene R
    Medicina (Kaunas); 2004; 40 Suppl 1():156-60. PubMed ID: 15079128
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pneumonectomy after high-dose radiation and concurrent chemotherapy for nonsmall cell lung cancer.
    Daly BD; Fernando HC; Ketchedjian A; Dipetrillo TA; Kachnic LA; Morelli DM; Shemin RJ
    Ann Thorac Surg; 2006 Jul; 82(1):227-31. PubMed ID: 16798219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survival after trimodality treatment for superior sulcus and central T4 non-small cell lung cancer.
    De Leyn P; Vansteenkiste J; Lievens Y; Van Raemdonck D; Nafteux P; Decker G; Coosemans W; Decaluwé H; Moons J; Lerut T
    J Thorac Oncol; 2009 Jan; 4(1):62-8. PubMed ID: 19096308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stage III non-small-cell lung cancer: population-based patterns of treatment in British Columbia, Canada.
    Vinod SK; Wai E; Alexander C; Tyldesley S; Murray N
    J Thorac Oncol; 2012 Jul; 7(7):1155-63. PubMed ID: 22617240
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patterns of disease failure after trimodality therapy of nonsmall cell lung carcinoma pathologic stage IIIA (N2). Analysis of Cancer and Leukemia Group B Protocol 8935.
    Kumar P; Herndon J; Langer M; Kohman LJ; Elias AD; Kass FC; Eaton WL; Seagren SL; Green MR; Sugarbaker DJ
    Cancer; 1996 Jun; 77(11):2393-9. PubMed ID: 8635112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Postoperative complications after combined neoadjuvant treatment of lung cancer.
    Fowler WC; Langer CJ; Curran WJ; Keller SM
    Ann Thorac Surg; 1993 Apr; 55(4):986-9. PubMed ID: 8385447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gender, Age, and Comorbidity Status Predict Improved Survival with Adjuvant Chemotherapy Following Lobectomy for Non-small Cell Lung Cancers Larger than 4 cm.
    Sandler BJ; Wang Z; Hancock JG; Boffa DJ; Detterbeck FC; Kim AW
    Ann Surg Oncol; 2016 Feb; 23(2):638-45. PubMed ID: 26474557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Two commonly used neoadjuvant chemoradiotherapy regimens for locally advanced stage III non-small cell lung carcinoma: long-term results and associations with pathologic response.
    Machtay M; Lee JH; Stevenson JP; Shrager JB; Algazy KM; Treat J; Kaiser LR
    J Thorac Cardiovasc Surg; 2004 Jan; 127(1):108-13. PubMed ID: 14752420
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Outcome of Surgical Treatment of Locally Advanced Lung Cancer after Induction Chemoradiotherapy].
    Tanahashi M; Yukiue H; Suzuki E; Yoshii N; Kitazawa S; Kaminuma Y; Niwa H
    Kyobu Geka; 2018 Apr; 71(4):278-283. PubMed ID: 29755101
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morbidity and mortality after major pulmonary resections in patients with locally advanced stage IIIA non-small cell lung carcinoma who underwent induction therapy.
    Peer M; Stav D; Cyjon A; Sandbank J; Vasserman M; Haitov Z; Sasson L; Schreiber L; Ezri T; Priel IE; Hayat H
    Heart Lung Circ; 2015 Jan; 24(1):69-76. PubMed ID: 25086910
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction chemoradiotherapy followed by surgery for locally advanced non-small cell lung cancer.
    Kusumoto S; Hirose T; Fukayama M; Kataoka D; Hamada K; Sugiyama T; Shirai T; Yamaoka T; Okuda K; Ohnishi T; Ohmori T; Kadokura M; Adachi M
    Oncol Rep; 2009 Nov; 22(5):1157-62. PubMed ID: 19787234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sleeve lobectomy as an alternative to pneumonectomy in patients with operable lung cancer.
    Kasprzyk M; Dyszkiewicz W; Piwkowski C; Brudlo M; Galecki B; Gabryel P; Gasiorowski L
    Neoplasma; 2013; 60(1):62-7. PubMed ID: 23067218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relationship Between Radiation Therapy Dose and Outcome in Patients Treated With Neoadjuvant Chemoradiation Therapy and Surgery for Stage IIIA Non-Small Cell Lung Cancer: A Population-Based, Comparative Effectiveness Analysis.
    Sher DJ; Fidler MJ; Seder CW; Liptay MJ; Koshy M
    Int J Radiat Oncol Biol Phys; 2015 Jun; 92(2):307-16. PubMed ID: 25838187
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preoperative concurrent radiation therapy and cisplatinum continuous infusion in IIIa (N2) non small cell lung cancer. A pilot study.
    Maggi G; Casadio C; Cianci R; Oliaro A; Molinatti M; Bretti S; Clerico M; Boidi-Trotti A; Rovea P
    J Cardiovasc Surg (Torino); 1994 Aug; 35(4):341-6. PubMed ID: 7929550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II trial of postoperative adjuvant paclitaxel/carboplatin and thoracic radiotherapy in resected stage II and IIIA non-small-cell lung cancer: promising long-term results of the Radiation Therapy Oncology Group--RTOG 9705.
    Bradley JD; Paulus R; Graham MV; Ettinger DS; Johnstone DW; Pilepich MV; Machtay M; Komaki R; Atkins J; Curran WJ;
    J Clin Oncol; 2005 May; 23(15):3480-7. PubMed ID: 15908657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.